Nitric oxide plays an important role on insulin's vasodilator effect as well as in states of insulin resistance, such as obesity and diabetes, characterized by reduced insulin-mediated vasodilatation subsequent to endothelial dysfunction. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.